학술논문
First-in-Human, Single- and Multiple-Ascending-Dose, Food-Effect, and Absolute Bioavailability Trials to Assess the Pharmacokinetics, Safety, and Tolerability of Pritelivir, a Nonnucleoside Helicase-Primase Inhibitor Against Herpes Simplex Virus in Healthy Subjects
Document Type
Article
Author
Source
In: Clinical Pharmacology in Drug Development . (Clinical Pharmacology in Drug Development, July 2023, 12(7):749-760)
Subject
Language
English
ISSN
21607648
2160763X
2160763X